MedTrace Logo

Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease

NCT04576923 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2023-08-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to prospectively evaluate the utility of Liver Incytes in assessing NAFLD with or without advanced fibrosis in patients seen in liver clinics for suspected NAFLD diagnosis.

Conditions

  • NAFLD
  • NASH - Nonalcoholic Steatohepatitis

Interventions

DIAGNOSTIC_TEST

Velacur by Sonic Incytes

liver stiffness measurement

Sponsors & Collaborators

  • Sonic Incytes

    collaborator INDUSTRY

  • Indiana University

    lead OTHER

Principal Investigators

  • Samer Gawrieh, MD · Indiana University School of Medicine

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-19
Primary Completion
2022-04-26
Completion
2022-04-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04576923 on ClinicalTrials.gov